BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Prognosis
19 results:

  • 1. SPP1 promotes radiation resistance through jak2/STAT3 pathway in esophageal carcinoma.
    Wang M; Sun X; Xin H; Wen Z; Cheng Y
    Cancer Med; 2022 Dec; 11(23):4526-4543. PubMed ID: 35593388
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma.
    Li M; Jin S; Zhang Z; Ma H; Yang X
    Cancer Lett; 2022 Feb; 527():28-40. PubMed ID: 34902522
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation of IL-6 and jak2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the jak2/STAT3 pathway.
    Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
    Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal cancer.
    Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
    Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SOX12 contributes to the activation of the jak2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
    Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
    Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High expression of novel biomarker KRT16P3 promotes the progression of tongue squamous cell carcinoma and predicts poor prognosis.
    Yang Y; Feng L; Ma H; Wang R; Fang J
    J Oral Pathol Med; 2021 Apr; 50(4):385-393. PubMed ID: 33220105
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
    Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
    J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a jak2/STAT3 signaling pathway.
    Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z
    J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
    Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
    Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting jak2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
    Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
    Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
    Front Immunol; 2018; 9():412. PubMed ID: 29599774
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
    Chen X; Wang L; Wang W; Zhao L; Shan B
    Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Overexpression of jak2: a predictor of unfavorable prognosis for nasopharyngeal carcinoma.
    He HL; Lee YE; Liang PI; Lee SW; Chen TJ; Chan TC; Hsing CH; Chang IW; Shiue YL; Li CF
    Future Oncol; 2016 Aug; 12(16):1887-96. PubMed ID: 27086650
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
    Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
    Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.
    Lee JJ; Wu X; Hildebrandt MA; Yang H; Khuri FR; Kim E; Gu J; Ye Y; Lotan R; Spitz MR; Hong WK
    Cancer Prev Res (Phila); 2011 Feb; 4(2):185-93. PubMed ID: 21292633
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.
    Coppo P; Gouilleux-Gruart V; Huang Y; Bouhlal H; Bouamar H; Bouchet S; Perrot C; Vieillard V; Dartigues P; Gaulard P; Agbalika F; Douay L; Lassoued K; Gorin NC
    Leukemia; 2009 Sep; 23(9):1667-78. PubMed ID: 19421230
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.